MAPT and Alzheimer disease: Also, for the definition of AD pathology, we chose a binary classification (presence/absence) using CSF p-tau181/Aβ1-42 as a marker of the concomitant presence of amyloid pathology and tau pathology [50–52] because of the relatively small sample size, not allowing for a more detailed classification such as the AT(N) [53].